Establishing a cardiovascular health and wellness program in a community pharmacy: Screening for metabolic syndrome

Journal of the American Pharmacists Association

Volumn 50, Issue 1, 2010, Pages 32-36

  Olenak, Julie L ^a,b   Calpin, Meghan ^c  

^a WILKES UNIVERSITY   (United States)

^b Medicine Shoppe Pharmacy   (United States)

^c Walgreens   (United States)

Author keywords

Cardiovascular risk management; Community pharmacy; Health screening; Metabolic syndrome; Pharmaceutical care

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH PROMOTION; HUMAN; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PHARMACY; PREVALENCE; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; PENNSYLVANIA; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 77952296049     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.08104     Document Type: Article

References (10)

1. American Heart Association. Metabolic syndrome. Accessed at www.americanheart.org/presenter.jhtml?identifier=4756, July 16, 2008.
2. Ford E, Giles W, Mokdad A. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27:2444-9.
3. Grundy S, Cleeman J, Daniels S, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112;2735-52.
4. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics 2008 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2008;117:e25-146.
5. Malik S, Wong N, Franklin S, et al. Impact of metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-50.
6. Ciaardulli L, Goode J. Using health observances to promote wellness in community pharmacies. J Am Pharm Assoc. 2003;43:13-6.
7. National Heart Lung and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Accessed at www.nhlbi.nih.gov/guidelines/hypertension, May 20, 2009.
8. National Cholesterol Education Program. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Accessed at www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf, August 7,2008.
9. McNeill A, Rosamond W, Girman C, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28:385-90.
10. Rodis J, Thomas RA. Stepwise approach to developing point-of-care testing services in the community/ambulatory pharmacy setting. J Am Pharm Assoc. 2006;46:594-604.